Stay updated on Ipilimumab + Lymphodepletion + ACT + HD IL-2 Melanoma Mets Clinical Trial

Sign up to get notified when there's something new on the Ipilimumab + Lymphodepletion + ACT + HD IL-2 Melanoma Mets Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Ipilimumab + Lymphodepletion + ACT + HD IL-2 Melanoma Mets Clinical Trial page

  1. Check
    4 days ago
    Change Detected
    Summary
    The page footer now includes Moffitt branding and related trial links. The revision label changed from v3.5.4 to v3.5.5.
    Difference
    0.3%
    Check dated 2026-06-05T23:55:54.000Z thumbnail image
  2. Check
    11 days ago
    Change Detected
    Summary
    The page’s footer now omits the H. Lee Moffitt Cancer Center branding and the sponsor-provided links to drug information, study documents, and helpful resources. This changes how the page references its affiliated institution and directs users to related materials.
    Difference
    0.3%
    Check dated 2026-05-29T23:00:27.000Z thumbnail image
  3. Check
    18 days ago
    No Change Detected
  4. Check
    25 days ago
    Change Detected
    Summary
    Revision label updated from v3.5.3 to v3.5.4, indicating a minor site/template update.
    Difference
    0.1%
    Check dated 2026-05-15T15:29:47.000Z thumbnail image
  5. Check
    47 days ago
    Change Detected
    Summary
    The page revision label was updated from **v3.5.2** to **v3.5.3**, indicating a newer site/application version for the same study record.
    Difference
    0.1%
    Check dated 2026-04-24T05:58:40.000Z thumbnail image
  6. Check
    54 days ago
    Change Detected
    Summary
    Revision label updated from v3.5.0 to v3.5.2.
    Difference
    0.1%
    Check dated 2026-04-17T02:28:56.000Z thumbnail image
  7. Check
    83 days ago
    Change Detected
    Summary
    Added Revision: v3.5.0 and removed Revision: v3.4.3.
    Difference
    0.1%
    Check dated 2026-03-19T04:53:17.000Z thumbnail image

Stay in the know with updates to Ipilimumab + Lymphodepletion + ACT + HD IL-2 Melanoma Mets Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Ipilimumab + Lymphodepletion + ACT + HD IL-2 Melanoma Mets Clinical Trial page.